CX3CL1 and breast cancer: CX3CR1 determines the arrest and initial lodging of breast cancer cells to transmigrate through endothelial cells and extravasate to lodge on to the skeleton in response to its ligand, Fractalkine (FKN/CX3CL1)49,50.